ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VRAYQ vs. BRSH, SDCCQ, GMVDF, AHPI, AFIB, NMRD, MOTS, UTRS, VIVE, and DRTSWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Acutus Medical (AFIB), Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Viveve Medical (VIVE), and Alpha Tau Medical (DRTSW). These companies are all part of the "medical equipment" industry. ViewRay vs. Its Competitors Bruush Oral Care SmileDirectClub G Medical Innovations Allied Healthcare Products Acutus Medical Nemaura Medical Motus GI Minerva Surgical Viveve Medical Alpha Tau Medical Bruush Oral Care (NASDAQ:BRSH) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings. Does the media favor BRSH or VRAYQ? In the previous week, Bruush Oral Care's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score. Company Overall Sentiment Bruush Oral Care Neutral ViewRay Neutral Which has higher earnings & valuation, BRSH or VRAYQ? Bruush Oral Care has higher earnings, but lower revenue than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruush Oral Care$2.92M0.00N/AN/AN/AViewRay$102.21M0.00-$107.33MN/AN/A Do insiders & institutionals hold more shares of BRSH or VRAYQ? 31.9% of Bruush Oral Care shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 29.8% of Bruush Oral Care shares are held by company insiders. Comparatively, 2.5% of ViewRay shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is BRSH or VRAYQ more profitable? Company Net Margins Return on Equity Return on Assets Bruush Oral CareN/A N/A N/A ViewRay N/A N/A N/A Which has more risk and volatility, BRSH or VRAYQ? Bruush Oral Care has a beta of 2.76, suggesting that its stock price is 176% more volatile than the S&P 500. Comparatively, ViewRay has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. SummaryBruush Oral Care beats ViewRay on 3 of the 4 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18K$35.23M$5.57B$9.31BDividend YieldN/AN/A4.23%4.03%P/E RatioN/A3.1228.6119.73Price / SalesN/A233.71412.31173.11Price / CashN/A41.3636.0257.96Price / BookN/A1.998.235.67Net Income-$107.33M-$2.66M$3.23B$257.79M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300BRSHBruush Oral CareN/AN/AN/AN/A$44K$2.92M0.0011Gap DownSDCCQSmileDirectClubN/AN/AN/A-97.5%$40K$470.74M0.002,700GMVDFG Medical InnovationsN/A$0.00flatN/A-98.6%$26K$4.42M0.0072AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16K$27.05M0.00150Gap UpAFIBAcutus MedicalN/A$0.00-90.0%N/A-92.7%$6K$7.16M0.00340News CoverageGap DownHigh Trading VolumeNMRDNemaura Medical1.156 of 5 starsN/AN/A-99.7%$4K$3.02K0.0040MOTSMotus GIN/A$0.00flatN/A-99.4%$2K$319K0.0030UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160VIVEViveve MedicalN/AN/AN/AN/A$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.24-14.5%N/A+9.2%$0.00N/A0.0080 Related Companies and Tools Related Companies Bruush Oral Care Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Allied Healthcare Products Alternatives Acutus Medical Alternatives Nemaura Medical Alternatives Motus GI Alternatives Minerva Surgical Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.